These pages are the citation record for compounds in the Osae Research catalog. Each overview is identity, CAS, molecular facts, mechanism in a research context, and literature pointers. They are not product pages. They are not dosing guides. They are not interchangeable with approved drug labels.
Cite an overview URL for “what is this molecule.” Use research notes for naming and labeling that applies across SKUs (GLP-3 is not a receptor, RUO vs 503A API, salt vs base, blend nicknames). Use a product page for vial size, lot COA access, and shipping. Lot PDFs are indexed at certificates of analysis.
All materials from Osae Research are for laboratory research use only. Not for human or veterinary use.
Incretin and glucagon-family peptides
These ligands act at GLP-1R, GIPR, and/or GCGR. There is no GLP-3 receptor. See GLP-3 is not a receptor.
- Retatrutide (LY3437943) – Reta GLP-3 supply
- Tirzepatide (LY3298176) – research Tirzepatide
- Semaglutide – research Semaglutide
GHRH-axis tools
These are not incretin agonists. Tesamorelin and CJC-1295 (no DAC) are GHRH-axis ligands. Ipamorelin is a ghrelin-receptor agonist. See GHRH-axis tools are not incretin agonists.
Fragments and catalog blends
GLOW, KLOW, and Wolverine are catalog nicknames, not combination-study arms. Read the COA for component list and CAS. See ignore the blend name; read the COA.
- BPC-157 – research BPC-157
- GHK-Cu – research GHK-Cu
- GLOW (BPC-157 / TB-500 / GHK-Cu) – research GLOW
- KLOW (BPC-157 / GHK-Cu / KPV) – research KLOW
- Wolverine (BPC-157 + TB-500) – research Wolverine
Mitochondrial peptide and cofactor
NAD+ is not a peptide. MOTS-c is a mitochondrial-derived peptide. Do not file either under GLP-1R.
Research notes (naming and labeling)
These notes are written once for the whole catalog. They are not SKU encyclopedias. Full list: Research notes.
- GLP-3 is not a receptor
- A research reagent is not 503A API
- Incretin salt forms are not the approved-drug base
- Nickname blends have no combination studies
- Ignore the blend name; read the COA
- Peptide incretin vs non-peptide oral GLP-1
- GHRH-axis tools are not incretin agonists
Last reviewed: 2026-11-08